Profile of Psoriasis Vulgaris Patients Treated with Methotrexate at Dr. Soetomo Hospital, Surabaya, 2017–2018
Background: Psoriasis Vulgaris is a chronic inflammatory skin disease that affects patients’ quality of life. Methotrexate is the first-line and most effective systemic therapy in psoriasis vulgaris management. Purpose: The aim of this study was to evaluate clinical improvement after methotrexate th...
Guardado en:
Autores principales: | Damayanti Damayanti, Karina Dyahtantri Pratiwi, Wisnu Triadi Nugroho |
---|---|
Formato: | article |
Lenguaje: | EN ID |
Publicado: |
Universitas Airlangga
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ed484b63fe349608bf8786821ccb304 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: Birgit Sadoghi, et al.
Publicado: (2021) -
Serum TSLP is a potential biomarker of psoriasis vulgaris activity
por: El-Ghareeb MI, et al.
Publicado: (2019) -
Analysis of herbs-combination of Professor Yang Su-qing in the treatment of psoriasis vulgaris with blood stasis syndrome
por: Xue Xiao, et al.
Publicado: (2021) -
Olive Oil Based Methotrexate Loaded Topical Nanoemulsion Gel for the Treatment of Imiquimod Induced Psoriasis-like Skin Inflammation in an Animal Model
por: Sheikh Abdur Rashid, et al.
Publicado: (2021) -
Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
por: Strohbuecker L, et al.
Publicado: (2019)